Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extended‐release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double‐blind, placebo‐controlled trial
S. Wayne Miles, Janie Sheridan, Bruce Russell, et al.
Addiction (2013) Vol. 108, Iss. 7, pp. 1279-1286
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature
Kelly E. Courtney, Lara A. Ray
Drug and Alcohol Dependence (2014) Vol. 143, pp. 11-21
Open Access | Times Cited: 430
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
Krista J. Siefried, Liam S. Acheson, Nicholas Lintzeris, et al.
CNS Drugs (2020) Vol. 34, Iss. 4, pp. 337-365
Open Access | Times Cited: 147
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging
Edythe D. London, Milky Kohno, Angelica M. Morales, et al.
Brain Research (2014) Vol. 1628, pp. 174-185
Open Access | Times Cited: 165
Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis
Vítor S. Tardelli, Adam Bisaga, Felipe B. Arcadepani, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2233-2255
Closed Access | Times Cited: 111
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder

Journal of Addiction Medicine (2024) Vol. 18, Iss. 1S, pp. 1-56
Closed Access | Times Cited: 13
Psychostimulant addiction treatment
Karran A. Phillips, David H. Epstein, Kenzie L. Preston
Neuropharmacology (2014) Vol. 87, pp. 150-160
Open Access | Times Cited: 73
Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder
Walter Ling, Linda Chang, Maureen Hillhouse, et al.
Addiction (2014) Vol. 109, Iss. 9, pp. 1489-1500
Open Access | Times Cited: 71
Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release
Nora D. Volkow, Gene‐Jack Wang, Lisa A. Smith, et al.
NeuroImage (2015) Vol. 121, pp. 20-28
Open Access | Times Cited: 67
Pharmacotherapy for amphetamine dependence: A systematic review
Nicole K. Lee, Linda Jenner, Angela Harney, et al.
Drug and Alcohol Dependence (2018) Vol. 191, pp. 309-337
Closed Access | Times Cited: 64
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
Chloe J. Jordan, Jianjing Cao, Amy Hauck Newman, et al.
Neuropharmacology (2019) Vol. 158, pp. 107609-107609
Open Access | Times Cited: 61
Classics in Chemical Neuroscience: Methylphenidate
Cody J. Wenthur
ACS Chemical Neuroscience (2016) Vol. 7, Iss. 8, pp. 1030-1040
Closed Access | Times Cited: 54
An initial randomized controlled trial of behavioral activation for treatment of concurrent crystal methamphetamine dependence and sexual risk for HIV acquisition among men who have sex with men
Matthew J. Mimiaga, David W. Pantalone, Katie B. Biello, et al.
AIDS Care (2019) Vol. 31, Iss. 9, pp. 1083-1095
Open Access | Times Cited: 53
Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis
Meha Bhatt, Laura Zielinski, Lola Baker-Beal, et al.
Systematic Reviews (2016) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
Farzin Rezaei, Maryam Emami, Shakiba Zahed, et al.
DARU Journal of Pharmaceutical Sciences (2015) Vol. 23, Iss. 1
Open Access | Times Cited: 44
Prescription psychostimulants for the treatment of amphetamine‐type stimulant use disorder: A systematic review and meta‐analysis of randomized placebo‐controlled trials
Heidar Sharafi, Hamzah Bakouni, Christina McAnulty, et al.
Addiction (2023) Vol. 119, Iss. 2, pp. 211-224
Open Access | Times Cited: 12
Psychostimulants
Andrew C. McCreary, Christian P. Müller, Małgorzata Filip
International review of neurobiology (2015), pp. 41-83
Closed Access | Times Cited: 39
Addictive potential of novel treatments for refractory depression and anxiety
Dušan Kolar
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 1513-1519
Open Access | Times Cited: 35
Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail
Hanis Mohammad Hazani, Isa Naina Mohamed, Muzaimi Mustapha, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications
Christopher D. Verrico, Colin N. Haile, Thomas F. Newton, et al.
Expert Opinion on Investigational Drugs (2013) Vol. 22, Iss. 12, pp. 1549-1568
Open Access | Times Cited: 32
Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders
Charlotte Skoglund, Lena Brandt, Brian M. D’Onofrio, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 11, pp. 1144-1152
Closed Access | Times Cited: 29
Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders
Charlotte Skoglund, Lena Brandt, Catarina Almqvist, et al.
Journal of Clinical Psychopharmacology (2016) Vol. 36, Iss. 3, pp. 222-228
Open Access | Times Cited: 28
Pharmacotherapeutic strategies for methamphetamine use disorder: mind the subgroups
Edna Soares, Frederico C. Pereira
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 18, pp. 2273-2293
Closed Access | Times Cited: 26
Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction
Danni Cao, Jingjing Shi, Wei Hao, et al.
European Journal of Pharmacology (2016) Vol. 780, pp. 129-135
Closed Access | Times Cited: 24
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
Xianghu He, Ewa Galaj, Guo‐Hua Bi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 18
Clinical management of psychostimulant withdrawal: review of the evidence
Michael J. Li, Steven Shoptaw
Addiction (2022) Vol. 118, Iss. 4, pp. 750-762
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top